Science Update: Maternal antibody treatment fails to reduce infant cytomegalovirus infection, NIH-funded study suggests
An antibody treatment in early pregnancy for women infected with cytomegalovirus does not appear to reduce the risk of infection or death among their newborns, an NIH-funded study suggests. The findings contradict several smaller studies on the treatment, known as hyperimmune globulin, that suggested the treatment was effective.